Navigating China IIT Importation Without Losing the Speed Advantage
China IITs Are Unique and Operationally Challenging Across the Clinical Supply Chain China IITs can offer advanced therapy sponsors a…
Perspective
Navigating Tariff Volatility: Strategic Pathways for Emerging Life Sciences Companies
New perspective from Gartner highlights that Chief Supply Chain Officers must plan for long-term volatility, considering potential countermeasures, escalations, and de-escalations.…
Perspective
Event Recap: TraceLink FutureLink Barcelona Conference 2024
TraceLink recently hosted FutureLink Barcelona 2024, their annual European meeting for supply chain participants. Since Europe enacted serialization requirements back…
Perspective
The Evolving Ecosystem for Biopharma Manufacturing
A significant – even seismic – shift is taking place in biopharma manufacturing and technical operations right now. It is…
Perspective
US-China Trade Tension: Increasing Uncertainty for Biopharma
In recent years, the US government has increasingly leveraged trade policy as a tool for broader U.S. foreign policy. This…
Perspective
Impact of Rejecting Chevron Deference on Biopharma
On June 28, the Supreme Court of the United States (SCOTUS) overruled the most cited legal case in its history, colloquially…
Perspective
Benefits of Using Foreign Trade Zones for Emerging Biotech Companies
We often see clients incurring high duties on importing key starting materials into the US. For emerging companies conducting R&D,…
Perspective
Global Trade Compliance: Why Emerging Biopharmaceutical Company Operations Executives Need to Take Notice
Today’s biopharmaceutical supply chains often stretch around the world. Key starting materials (KSM) and API originate more frequently from Asia.…
Perspective
5 Unique Logistics Challenges for Specialty Pharmaceuticals
Many of our clients are innovator companies developing novel treatments that are often complex and extremely high value. As a…